Cediranib therapy decreases tumor blood volume. by Christian T. Farrar (355177)

“…<p>(left) After 2–3 days of treatment, a statistically significant (p<0.01) difference in the rCBV (±SEM) was observed between cediranib and control groups with a 16.5±2.2% decrease for cediranib treated animals and a 14.1±2.3% increase for control animals. …”

Nicotine-induced Tumor Growth is decreased by BEL. by Lindsay E. Calderon (332344)

BRCA1 silencing decreases cell viability. by Pei Chen (252989)

Purine nucleotides are decreased in long-term hypoxia. by Emily B. Cohen (9106088)

L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

“…<b>F</b>) The number of activated T-cells (CD4⁺CD44⁺) remained unchanged after 6 weeks of HCD (n = 5–7; p = n.s.) and decreased after 12 weeks of HCD (n = 5–7; ^*p<0.05) as compared to control.…”

FTY720 decreases cerebral lymphocyte invasion. by Arthur Liesz (349478)

Complex I inhibitor decreases ROS level by Zheng Li (26302)

BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

“…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10⁻⁵). …”

Decreased function of Nrf2 in the aging heart. by Sellamuthu S. Gounder (306106)

“…<p>(<b>A</b>) <b>Decreased nuclear translocation of Nrf2 is evident in the heart of aging mice.…”

Erlotinib decreases hypoxia <i>in vivo</i>. by George J. Cerniglia (261405)

Decreased IDE-proteasome interaction during the HSR. by Diego Sbardella (173620)

Decreased fetal weight in CrryshRNA mice. by Manu Banadakoppa (9199271)

“…<p>Fetal and placental weights were measured at 17.5 dpc soon after euthanasia (n = 5–7), A) Average fetal weight was significantly reduced (<i>p</i> = 0.048) in CrryshRNA mice compared to control group B) Average placental weight was not different between the two groups C) Fetal-placental weight ratio was significantly decreased (<i>p</i> = 0.045) in Crry shRNA mice compared to control mice.…”

L-NNA treatment decreases tumor blood flow and increases hypoxia. by Robert J. G. Cardnell (350872)

“…Data presented as mean intensity as a percentage of control ± SEM; n = 5; *** = p<0.01. …”

Reducing the catalyst concentration decreases elasticity of elastomers. by Viktor Heinrichs (5071448)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Decreased focus score in early treated mice. by Nienke Roescher (159484)

Decreased Jak2 activity in coated pit. by Joyce Putters (356255)

Decreased FOXP3 Treg induction in LAG-3 KO cells <i>in vitro</i>. by Nicholas M. Durham (174371)

Sphere-forming efficiency decreases following radiation. by Vicky T. Nguyen (5029244)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”